A business in context

BCYC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-08-18 · 0001104659-26-099221 · Items 5.02

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001104659-26-088457

  3. 8-K · Current report

    Report date 2026-07-30 · 0001104659-26-088455 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-07-15 · 0002119908-26-000009

  5. 4 · Ownership change

    Report date 2026-07-15 · 0002015378-26-000008

  6. 4 · Ownership change

    Report date 2026-07-15 · 0001983944-26-000010

  7. 4 · Ownership change

    Report date 2026-07-15 · 0001776582-26-000008

  8. 4 · Ownership change

    Report date 2026-07-02 · 0002119908-26-000007

  9. 4 · Ownership change

    Report date 2026-07-02 · 0002015378-26-000006

  10. 4 · Ownership change

    Report date 2026-07-02 · 0001983944-26-000008

  11. 4 · Ownership change

    Report date 2026-07-02 · 0001776938-26-000006

  12. 8-K · Current report

    Report date 2026-06-17 · 0001104659-26-075451 · Items 5.07

  13. 8-K · Current report

    Report date 2026-05-21 · 0001104659-26-065231 · Items 8.01,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001104659-26-052117

  15. 8-K · Current report

    Report date 2026-04-30 · 0001104659-26-052107 · Items 2.02,9.01

  16. DEF 14A · Proxy statement

    Report date 2026-06-17 · 0001104659-26-046806

  17. 8-K · Current report

    Report date 2026-04-20 · 0001104659-26-045198 · Items 8.01,9.01

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001104659-26-028971

  19. 8-K · Current report

    Report date 2026-03-17 · 0001104659-26-028954 · Items 2.02,5.02,9.01

  20. 8-K · Current report

    Report date 2026-01-29 · 0001104659-26-009501 · Items 5.02

  21. 8-K · Current report

    Report date 2026-01-12 · 0001104659-26-002706 · Items 8.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001104659-25-104010

  23. 8-K · Current report

    Report date 2025-10-30 · 0001104659-25-104004 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-09-08 · 0001104659-25-088238 · Items 5.02,9.01

  25. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001558370-25-010843

  26. 8-K · Current report

    Report date 2025-08-06 · 0001104659-25-075435 · Items 2.02,5.02,9.01

  27. 8-K · Current report

    Report date 2025-06-17 · 0001104659-25-060316 · Items 5.07

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001558370-25-006049

  29. 8-K · Current report

    Report date 2025-05-01 · 0001104659-25-043014 · Items 2.02,9.01

  30. 8-K · Current report

    Report date 2025-04-29 · 0001104659-25-040625 · Items 7.01,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-06-17 · 0001558370-25-005258

  32. 8-K · Current report

    Report date 2025-03-21 · 0001104659-25-028531 · Items 5.02,8.01,9.01

  33. 8-K · Current report

    Report date 2025-03-12 · 0001104659-25-023934 · Items 5.08

  34. 10-K · Annual report

    Report date 2024-12-31 · 0001558370-25-001438

  35. 8-K · Current report

    Report date 2025-02-25 · 0001104659-25-016709 · Items 2.02,9.01

  36. 8-K · Current report

    Report date 2025-01-13 · 0001104659-25-003026 · Items 7.01,8.01,9.01

  37. SC 13D/A · Ownership disclosure

    0001104659-24-129475

  38. 8-K · Current report

    Report date 2024-12-13 · 0001104659-24-128241 · Items 8.01,9.01

  39. SC 13G/A · Ownership disclosure

    0001104659-24-119294

  40. SC 13G/A · Ownership disclosure

    0001104659-24-119027

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 11 transaction rows11SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

11 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-04-06
2026-04-06
Perry Jennifer Scott
10b5-1 checkbox reported
S · Sale
Disposed
Ordinary Shares37.05.05
2026-04-06
2026-04-06
Perry Jennifer Scott
10b5-1 checkbox reported
S · Sale
Disposed
Ordinary Shares333.05.04
2026-04-06
2026-04-06
Hannay Michael Charles FergusonS · Sale
Disposed
Ordinary Shares251.05.05
2026-04-06
2026-04-06
Thompson Travis AlvinS · Sale
Disposed
Ordinary Shares102.05.05
2026-04-06
2026-04-06
Lee KevinS · Sale
Disposed
Ordinary Shares1716.05.05
2026-04-06
2026-04-06
Skynner MichaelS · Sale
Disposed
Ordinary Shares525.05.05
2026-04-02
2026-04-06
Perry Jennifer Scott
10b5-1 checkbox reported
S · Sale
Disposed
Ordinary Shares1038.04.91
2026-04-02
2026-04-06
Hannay Michael Charles FergusonS · Sale
Disposed
Ordinary Shares1521.04.91
2026-04-02
2026-04-06
Thompson Travis AlvinS · Sale
Disposed
Ordinary Shares799.04.91
2026-04-02
2026-04-06
Lee KevinS · Sale
Disposed
Ordinary Shares5967.04.91
2026-04-02
2026-04-06
Skynner MichaelS · Sale
Disposed
Ordinary Shares1879.04.91

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001761612BICYCLE THERAPEUTICS PLC

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
213800XKUI6R7GKC3E43
GLEIF legal name
BICYCLE THERAPEUTICS PLC
Entity / LEI registration status
ACTIVE / ISSUED
Reference data updated
2026-02-14T21:28:13Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Bicycle Therapeutics (United Kingdom) · alias · wikidata
  • BICYCLE THERAPEUTICS Ltd · former SEC name · 2018-12-21 to 2019-05-24
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$35.27M$37.55M
2023-12-31$26.98M$29.56M
2022-12-31$14.46M$16.50M
2021-12-31$11.70M$14.41M
2020-12-31$10.39M$13.41M
2019-12-31$13.80M$18.02M
2018-12-31$7.14M$9.49M
2017-12-31$2.06M$2.81M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗